MedKoo Cat#: 597914 | Name: Hexadecylphosphoserine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Hexadecylphosphoserine is a growth inhibitory representative.

Chemical Structure

Hexadecylphosphoserine
Hexadecylphosphoserine
CAS#133321-35-4

Theoretical Analysis

MedKoo Cat#: 597914

Name: Hexadecylphosphoserine

CAS#: 133321-35-4

Chemical Formula: C19H40NO6P

Exact Mass: 409.2593

Molecular Weight: 409.50

Elemental Analysis: C, 55.73; H, 9.85; N, 3.42; O, 23.44; P, 7.56

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Hexadecylphosphoserine; Hexadecyl phosphoserine; Hexadecyl-phosphoserine; Hexadecylphospho-L-serine;
IUPAC/Chemical Name
O-((hexadecyloxy)(hydroxy)phosphoryl)-L-serine
InChi Key
DVFFVSCWYBNHJP-SFHVURJKSA-N
InChi Code
InChI=1S/C19H40NO6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-25-27(23,24)26-17-18(20)19(21)22/h18H,2-17,20H2,1H3,(H,21,22)(H,23,24)/t18-/m0/s1
SMILES Code
N[C@@H](COP(O)(OCCCCCCCCCCCCCCCC)=O)C(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 409.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Bergmann J, Junghahn I, Brachwitz H, Langen P. Multiple effects of antitumor alkyl-lysophospholipid analogs on the cytosolic free Ca2+ concentration in a normal and a breast cancer cell line. Anticancer Res. 1994 Jul-Aug;14(4A):1549-56. PubMed PMID: 7979184. 2: Grunicke HH, Maly K, Uberall F, Schubert C, Kindler E, Stekar J, Brachwitz H. Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction. Adv Enzyme Regul. 1996;36:385-407. PubMed PMID: 8869757. 3: Geilen CC, Haase A, Wieder T, Arndt D, Zeisig R, Reutter W. Phospholipid analogues: side chain- and polar head group-dependent effects on phosphatidylcholine biosynthesis. J Lipid Res. 1994 Apr;35(4):625-32. PubMed PMID: 8006517. 4: Langen P, Maurer HR, Brachwitz H, Eckert K, Veit A, Vollgraf C. Cytostatic effects of various alkyl phospholipid analogues on different cells in vitro. Anticancer Res. 1992 Nov-Dec;12(6B):2109-12. PubMed PMID: 1295455. 5: Bergmann J, Langen P, Thomas Y, Brachwitz H. Opposite effects on cytosolic Ca2+ of antitumor phospholipids by induction of calcium influx and activation of endoplasmic reticulum Ca(2+)-ATPase. Cell Calcium. 1998 Apr;23(4):241-9. PubMed PMID: 9681187.